Literature DB >> 8413413

Clinical implications of the p53 tumor-suppressor gene.

C C Harris1, M Hollstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8413413     DOI： 10.1056/NEJM199310283291807

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  262 in total

1.  Comparison of mutant and wild-type p53 proteins in Merkel cell carcinoma.

Authors:  H J Carson; N E Lueck; B C Horten
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

Review 3.  Demystified ... p53.

Authors:  S J Darnton
Journal:  Mol Pathol       Date:  1998-10

4.  Molecular biology of Barrett's esophagus and esophageal cancer:role of p53.

Authors:  Alan G Casson
Journal:  World J Gastroenterol       Date:  1998-08       Impact factor: 5.742

Review 5.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

6.  Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.

Authors:  Christian Melle; Heinz-Peter Nasheuer
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

7.  Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin.

Authors:  Z P Ren; A Ahmadian; F Pontén; M Nistér; C Berg; J Lundeberg; M Uhlén; J Pontén
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

8.  Effect of subcellular localization of P21 on proliferation and apoptosis of HepG2 cells.

Authors:  Rongyuan Qiu; Songbai Wang; Xihua Feng; Feng Chen; Kaikai Yang; Shengsong He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

9.  The relation of mutant p53 accumulation in transitional cell carcinoma of bladder with pathological stage, grade, recurrence and survival.

Authors:  C O Yeniyol; T Süelözgen; E Vardar; S Sural; H Postaci; A R Ayder
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

10.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.